1 / 8

Main achievements and further developments

10 th Stakeholders’ meeting 15 th of March, 2007. 2006 and beyond:. Main achievements and further developments. Overcoming HIV/AIDS epidemic in Ukraine (programme supported by the Global Fund). Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine.

lenore-trujillo
Télécharger la présentation

Main achievements and further developments

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 10th Stakeholders’ meeting 15th of March, 2007 2006 and beyond: Main achievements and further developments Overcoming HIV/AIDS epidemic in Ukraine (programme supported by the Global Fund) Andriy Klepikov Executive Director,International HIV/AIDS Alliance in Ukraine

  2. Expenditure – Budget vs. Actual 2006

  3. Expenditure profile Alliance’s expenditure structure within Global Fund Project:from 1 January 2006— 31December 2006

  4. 2006 key results: • 3730 people (3178 adults and 552 children) are receiving antiretroviral therapy; • 1836 (4487 cumulatively since 2004) HIV-positive pregnant women received ARV to prevent mother-to-child transmission of HIV before and during labour during 2006; • 436 opiate-dependent people are receiving substitution maintenance therapy; • the groups most vulnerable to HIV have access to prevention and information services, including over110,000 injecting drug users, over 15,000 women involved in commercial sex and over 29,000 of prisoners; • 406 medical institutions in all regions of Ukraine received medicines and other medical supplies www.aidsalliance.org.ua

  5. Key results: • Scaling up of ARV therapy has influenced declining in the AIDS mortality growth rate; • Introduction of the substitution maintenance treatment has demonstrated posive implications. The examples include: - a number of clients survived from death while being on SMT; - crime rate falls dramatically among SMT’s clients; - Illegal drug business loses significant money income from drug users reoriented on SMT; • In the area of HIV prevention several promising innovations were started (pharmacy initiative, peer driven interventions, VCT with rapid tests, community centres); • Round 6 process had very positive implications for the R1 grant (incl. progress with the methadone registration, substantial increase in the national AIDS budget for 2007 etc.) www.aidsalliance.org.ua

  6. Challenges: • Several indicators were not met in 2006, particularly, the ones related to substitution maintenance treatment and prevention of mother-to-child transmission; • Lack of clear and consistent governmental policy in regard to sufficient rolling out of the substitution therapy maintenance treatment with methadone • In order to make an impact, HIV prevention efforts require more substantial funding over the next years • Over 2007 clear confidence should be built to pick up with governmental funding Round 1 activities related to ARV treatment and PMTCT www.aidsalliance.org.ua

  7. 2007 targets • 5,040patients on ART (including 725 children) • 3,500IDUs on ST (850 of which also on ART); • 7,325pregnant women receive PMTCT (cumulative target starting 2004); • 24,500 PLHA access non-clinical care & support (including 3,000 children) • 128,000 IDUs • 12,500sex workers access prevention services • 17,000 prisoners www.aidsalliance.org.ua

  8. Next steps • Harmonization with Round 6 programme and with resumed World Bank loan project as well as with other major interventions including national and locally funded programmes • Addressing programme challenges e.g. ARV treatment dropouts, growing needs in substitution therapy, and coverage of most at risk populations and PLHA • Year 5 planning (October 2007 – September 2008) including incorporation of the savings to bridge Round 6 timetable • Recommendations from the external evaluation of the grant will be applied for the current and Round 6 grants as well as for the overall country response www.aidsalliance.org.ua

More Related